Policy & Regulation
Forever Labs Raises USD 2m for Stem Cell Research
16 May 2018 - - Ann Arbor, Michigan-based longevity company Forever Labs has closed USD 2m in financing from Northwestern Mutual, Silicon Badia Ventures, Babel Ventures, Aaron Hirschhorn, founder and CEO of DogVacay, and notable members of the medical community including Dr. Michael Dobryansky, Dr. Timothy Davis, Dr. Michael Schenden, among others, the company said.
Forever Labs will dedicate resources to continue pioneering stem cell research breakthroughs and accelerate brand development.
Founded in 2015, Forever Labs is transforming the healthcare industry by preserving healthy stem cells for future therapies that combat age-related diseases, as well as aging itself.
Its proprietary procedure involves a certified Forever Labs physician collecting one's mesenchymal stem cells (MSCs), which have the ability to stimulate tissues to grow and repair themselves when most needed.
After a brief outpatient procedure, the stem cells are cryogenically frozen and safely stored agnostically in an FDA-compliant clinical-grade biorepository until needed.
Forever Labs was created to preserve healthy stem cells to later rejuvenate one's MSC population to significantly delay the onset of those age-related diseases and extend a healthy lifespan.


Related Headlines